Menu
Back to User profile » Dr Christopher Wright
Papers published by Dr Christopher Wright:
Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
Elbarky AM
Clinical Ophthalmology 2020, 14:823-830
Published Date: 16 March 2020
Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema
Coney JM
International Medical Case Reports Journal 2019, 12:161-169
Published Date: 31 May 2019
Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
McCluskey JD, Kaufman PL, Wynne K, Lewis G
International Medical Case Reports Journal 2019, 12:93-102
Published Date: 11 April 2019
The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema
Singh P, Chedid A, Deuchler SK, Kohnen T, Müller M, Koch FH
International Medical Case Reports Journal 2018, 11:265-269
Published Date: 15 October 2018
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
Hall J
Clinical Ophthalmology 2016, 10:1631-1632
Published Date: 25 August 2016
Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema
Hall J
Drug Design, Development and Therapy 2016, 10:1543-1546
Published Date: 20 April 2016
Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
Hall J
Clinical Ophthalmology 2015, 9:2119-2121
Published Date: 16 November 2015